Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study
Kawashima, Makoto, Nemoto, Osamu, Honda, Mariko, Watanabe, Daisuke, Nakayama, Juichiro, Imafuku, Shinichi, Kato, Toshiyuki, Katsuramaki, TsuneoLanguage:
english
Journal:
The Journal of Dermatology
DOI:
10.1111/1346-8138.13948
Date:
July, 2017
File:
PDF, 217 KB
english, 2017